2 Rheumatoid Arthritis Clinical Trials in Spokane, WA (2026)

Q: How do I join a clinical trial in Spokane?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Spokane research site will contact you.

Recruiting Rheumatoid Arthritis Studies in Spokane

NCT07144345Recruiting

Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp

This Phase 3, randomized, multi-center, evaluator-blind, vehicle-controlled study evaluates the efficacy and safety of reformulated Levulan Kerastick (aminolevulinic acid HCl 20%) combined with photod...

Spokane, WAPHASE3160 participantsSun Pharmaceutical Industries, Inc.

View Study Details

NCT05846451Recruiting

Evaluating a Potential Pharmacokinetic Kratom-oxycodone Interaction Concurrent With Clinical Endpoints

The goal of this study is to investigate whether the botanical product kratom affects how the body processes the opioid drug oxycodone. The main research questions to be answered are two-fold: 1. How...

Spokane, WAEARLY_PHASE116 participantsWashington State University

View Study Details

About Rheumatoid Arthritis Clinical Trials in Spokane

Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting approximately 1.3 million Americans, where the immune system mistakenly attacks joint linings, causing painful swelling, bone erosion, and joint deformity. Early diagnosis and treatment are critical to prevent irreversible damage. Current standard treatments include methotrexate and other DMARDs, TNF inhibitors (etanercept, infliximab), IL-6 inhibitors (tocilizumab), T-cell costimulation modulators (abatacept), and JAK inhibitors (tofacitinib, baricitinib). Clinical trials are now exploring next-generation targeted therapies, dual-pathway inhibitors, and treatment strategies aimed at achieving sustained remission rather than just symptom control. Patients with inadequate response to conventional DMARDs or biologics are commonly eligible for enrollment.

There are currently 2 rheumatoid arthritis clinical trials recruiting participants in Spokane, WA. These studies are seeking a combined 176 participants. Research is being sponsored by Sun Pharmaceutical Industries, Inc., Washington State University. Clinical trial participation is free and participants receive study-related medical care at no cost.

Rheumatoid Arthritis Clinical Trials in Spokane — FAQ

Are there rheumatoid arthritis clinical trials in Spokane?

Yes, there are 2 rheumatoid arthritis clinical trials currently recruiting in Spokane, WA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Spokane?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Spokane research site will contact you about next steps.

Are clinical trials in Spokane free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Spokane studies also compensate for your time and travel.

What rheumatoid arthritis treatments are being tested?

The 2 active trials in Spokane are testing new therapies including novel drugs, biologics, and treatment approaches for rheumatoid arthritis.

Data updated July 18, 2026 from ClinicalTrials.gov